MedTrace Logo

Safety and Efficacy of Sufentanil Administration by Paramedics in Acute Trauma

NCT06514469 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2024-07-23

No results posted yet for this study

Summary

The safety and efficacy of competence of paramedics to administer sufentanil intravenously in adult acute trauma patients without presence or without phone-call consult with an emergency medical doctor will be assessed in this observational study.

Condition or disease: pain in trauma or injury. Intervention/treatment: sufentanil administered by paramedics after the phone call consultation of medical doctor versus sufentanil administered by paramedics based on their competency, without consultation of medical doctor.

Conditions

  • Injury Traumatic
  • Pain, Acute

Interventions

DRUG

Sufentanil intravenous administration followed consultation of remote physician

Intravenous administration of sufentanil to patients with acute injury by paramedics only after phone-call consultation of medical doctor.

DRUG

Sufentanil intravenous administration based on paramedic competency

Intravenous administration of sufentanil to patients with acute injury by paramedics based on their competencies

Sponsors & Collaborators

  • Zdravotnicka Zachranna Sluzba Karlovarskeho Kraje, P.O.

    lead OTHER

Principal Investigators

  • Jiří Smetana, MD · Zdravotnická záchranná služba Karlovarského kraje, příspěvková organizace

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-01
Primary Completion
2024-12-31
Completion
2025-03-31

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06514469 on ClinicalTrials.gov